Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Buy

Security Buy Sell Buy (1M) Sell (1M) Price Target price ▲ Potential
Virbac S.A. 1 0 0 0 €345.00 - -
Natural Alternat. 18 1 1 0 €6.30 - -
Vericel Corp. 1 0 0 0 €41.80 - -
Aldeyra Therapeutics Inc. 2 0 0 0 €3.67 - -
Clinica Baviera S.A. 2 0 0 0 €27.90 - -
M1 Kliniken AG 2 0 0 0 €13.30 - -
Brainstorm Cell 1 0 0 0 €0.50 - -
Immunogen Inc. 6 0 0 0 €28.97 - -
Paul Hartmann AG 3 0 0 0 €209.00 - -
Trinity Biotech ADR 23 0 2 0 €0.41 - -
Pro-Dex Inc. 16 0 0 0 €16.70 - -
Acorda Therapeutics Cdt 14 0 1 0 €0.47 - -
Stratec SE 2 0 0 0 €42.10 - -
Lemaitre Vascular Inc 1 0 0 0 €59.00 - -
ShockWave Medical Inc 1 0 0 0 €306.80 - -
Viracta Therapeutics Inc. 2 0 2 0 €0.81 - -
Vitrolife AB 3 0 0 0 €13.96 - -
Clinuvel Pharmaceuticals 1 0 0 0 €9.06 - -
Adaptimmune Therapeutics PLC ADR 1 1 0 1 €1.00 €1.50 50.000%
Motus GI Holdings Inc. 2 0 0 0 €0.43 €2.33 443.991%
X4 Pharmaceuticals, Inc. 4 0 1 0 €1.09 €2.76 153.003%
ProQR Therapeutics N.V. 6 0 1 0 €1.89 €2.81 48.695%
Cutera Inc. 1 0 0 0 €1.99 €3.00 51.057%
Akebia Therapeutics Inc. 8 3 2 1 €1.25 €3.60 188.389%
Adverum Biotechnologies Inc. 4 1 0 0 €1.38 €3.70 168.304%